Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04501822
Status:
COMPLETED
Last Update Posted:
2022-04-27
First Post:
2020-07-28
Brief Title:
One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia
Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences
Organization:
Tomsk National Research Medical Center of the Russian Academy of Sciences
Study Overview
Official Title:
One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia
Status:
COMPLETED
Status Verified Date:
2022-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of the study is to assess the cardiac status of COVID-19 pneumonia patients during 1 year after discharge
Detailed Description:
Although COVID-19 manifests in most cases with respiratory symptoms cardiovascular abnormalities is common in hospitalized patients Patients with cardiovascular risk factors or established disease appear to have a worse prognosis Myocardial dysfunction could be a direct manifestation of COVID-19 The investigators hypothesize that subjects after COVID-19 pneumonia present myocardial and vascular remodeling during 1 year after discharge even in the absence of prior cardiovascular disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None